PDB Short entry for 6G78 HEADER TRANSFERASE 04-APR-18 6G78 TITLE RSK4 N-TERMINAL KINASE DOMAIN S232E IN COMPLEX WITH AMP-PNP COMPND MOL_ID: 1; COMPND 2 MOLECULE: RIBOSOMAL PROTEIN S6 KINASE ALPHA-6; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: S6K-ALPHA-6,90 KDA RIBOSOMAL PROTEIN S6 KINASE 6,P90RSK6, COMPND 5 RIBOSOMAL S6 KINASE 4,RSK-4,PP90RSK4; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RPS6KA6, RSK4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-1 KEYWDS RSK4, AGC KINASE, P90 RIBOSOMAL S6 KINASES, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR F.PRISCHI,M.M.ALI REVDAT 6 17-JAN-24 6G78 1 REMARK REVDAT 5 11-AUG-21 6G78 1 REMARK REVDAT 4 28-JUL-21 6G78 1 JRNL REVDAT 3 10-JUL-19 6G78 1 REMARK REVDAT 2 08-MAY-19 6G78 1 REMARK LINK REVDAT 1 17-APR-19 6G78 0 JRNL AUTH S.CHRYSOSTOMOU,R.ROY,F.PRISCHI,L.THAMLIKITKUL,K.L.CHAPMAN, JRNL AUTH 2 U.MUFTI,R.PEACH,L.DING,D.HANCOCK,C.MOORE,M.MOLINA-ARCAS, JRNL AUTH 3 F.MAURI,D.J.PINATO,J.M.ABRAHAMS,S.OTTAVIANI,L.CASTELLANO, JRNL AUTH 4 G.GIAMAS,J.PASCOE,D.MOONAMALE,S.PIRRIE,C.GAUNT,L.BILLINGHAM, JRNL AUTH 5 N.M.STEVEN,M.CULLEN,D.HROUDA,M.WINKLER,J.POST,P.COHEN, JRNL AUTH 6 S.J.SALPETER,V.BAR,A.ZUNDELEVICH,S.GOLAN,D.LEIBOVICI,R.LARA, JRNL AUTH 7 D.R.KLUG,S.N.YALIRAKI,M.BARAHONA,Y.WANG,J.DOWNWARD, JRNL AUTH 8 J.M.SKEHEL,M.M.U.ALI,M.J.SECKL,O.E.PARDO JRNL TITL REPURPOSED FLOXACINS TARGETING RSK4 PREVENT CHEMORESISTANCE JRNL TITL 2 AND METASTASIS IN LUNG AND BLADDER CANCER. JRNL REF SCI TRANSL MED V. 13 2021 JRNL REFN ESSN 1946-6242 JRNL PMID 34261798 JRNL DOI 10.1126/SCITRANSLMED.ABA4627 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : TWIN_LSQ_F REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.52 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 26055 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.227 REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.850 REMARK 3 FREE R VALUE TEST SET COUNT : 1263 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.5169 - 5.1922 0.95 2792 138 0.2153 0.1863 REMARK 3 2 5.1922 - 4.1252 0.95 2767 143 0.1763 0.1947 REMARK 3 3 4.1252 - 3.6049 0.95 2753 150 0.2008 0.2221 REMARK 3 4 3.6049 - 3.2759 0.95 2749 128 0.2266 0.2341 REMARK 3 5 3.2759 - 3.0413 0.94 2714 159 0.2552 0.2616 REMARK 3 6 3.0413 - 2.8622 0.95 2758 146 0.2521 0.3119 REMARK 3 7 2.8622 - 2.7190 0.95 2727 130 0.2783 0.3466 REMARK 3 8 2.7190 - 2.6007 0.95 2746 145 0.3094 0.3349 REMARK 3 9 2.6007 - 2.5006 0.96 2766 120 0.3157 0.3104 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.840 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: 0.2800 REMARK 3 OPERATOR: H,-K,-L REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 4671 REMARK 3 ANGLE : 0.968 6313 REMARK 3 CHIRALITY : 0.046 700 REMARK 3 PLANARITY : 0.004 788 REMARK 3 DIHEDRAL : 16.143 1731 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6G78 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-APR-18. REMARK 100 THE DEPOSITION ID IS D_1200009401. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979480 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26061 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 28.520 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.02500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 2.3600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6G77 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 % PEG 6000, 0.1 M TRIS PH8, 2 MM REMARK 280 ZINC CHLORIDE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 55.30700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 43 REMARK 465 PRO A 44 REMARK 465 LEU A 45 REMARK 465 GLY A 46 REMARK 465 SER A 47 REMARK 465 ASP A 48 REMARK 465 GLU A 49 REMARK 465 GLY A 50 REMARK 465 ARG A 117 REMARK 465 VAL A 118 REMARK 465 ARG A 119 REMARK 465 THR A 120 REMARK 465 LYS A 121 REMARK 465 MET A 122 REMARK 465 GLU A 123 REMARK 465 ARG A 124 REMARK 465 GLU A 227 REMARK 465 LYS A 228 REMARK 465 LYS A 229 REMARK 465 ALA A 230 REMARK 465 TYR A 231 REMARK 465 GLU A 232 REMARK 465 PHE A 233 REMARK 465 CYS A 234 REMARK 465 GLY B 43 REMARK 465 PRO B 44 REMARK 465 LEU B 45 REMARK 465 GLY B 46 REMARK 465 SER B 47 REMARK 465 ASP B 48 REMARK 465 GLU B 49 REMARK 465 GLY B 50 REMARK 465 ARG B 117 REMARK 465 VAL B 118 REMARK 465 ARG B 119 REMARK 465 THR B 120 REMARK 465 LYS B 121 REMARK 465 MET B 122 REMARK 465 GLU B 123 REMARK 465 ARG B 124 REMARK 465 ASP B 225 REMARK 465 GLN B 226 REMARK 465 GLU B 227 REMARK 465 LYS B 228 REMARK 465 LYS B 229 REMARK 465 ALA B 230 REMARK 465 TYR B 231 REMARK 465 GLU B 232 REMARK 465 PHE B 233 REMARK 465 CYS B 234 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 115 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 147 CG CD CE NZ REMARK 470 ARG A 197 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 225 CG OD1 OD2 REMARK 470 ASN A 279 CG OD1 ND2 REMARK 470 LYS B 53 CG CD CE NZ REMARK 470 GLU B 63 CG CD OE1 OE2 REMARK 470 GLU B 66 CG CD OE1 OE2 REMARK 470 LYS B 147 CG CD CE NZ REMARK 470 ARG B 197 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 247 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 278 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 319 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 105 O2A ANP A 401 1.84 REMARK 500 NZ LYS A 200 O1G ANP A 401 2.02 REMARK 500 O LEU A 169 O HOH A 501 2.06 REMARK 500 O HOH B 501 O HOH B 541 2.06 REMARK 500 OG SER A 165 O HOH A 502 2.08 REMARK 500 OD2 ASP B 97 OH TYR B 102 2.13 REMARK 500 O LEU B 169 O HOH B 501 2.16 REMARK 500 O HOH A 512 O HOH A 539 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLU A 145 NH1 ARG B 248 2445 1.41 REMARK 500 NH1 ARG A 247 OH TYR B 149 2545 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 197 -61.25 63.94 REMARK 500 ASP A 198 79.40 -108.77 REMARK 500 PHE A 217 52.15 -156.88 REMARK 500 THR A 236 79.35 57.69 REMARK 500 ARG A 247 47.86 72.67 REMARK 500 PHE A 308 53.38 -92.05 REMARK 500 ALA A 313 -4.29 67.64 REMARK 500 THR B 58 -59.42 -129.48 REMARK 500 LEU B 76 -64.45 -108.66 REMARK 500 THR B 144 -136.97 -126.96 REMARK 500 GLU B 145 70.17 -68.44 REMARK 500 ARG B 197 -79.87 55.09 REMARK 500 PHE B 217 53.91 -146.16 REMARK 500 PHE B 330 34.12 -98.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ANP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ANP B 401 DBREF 6G78 A 48 349 UNP Q9UK32 KS6A6_HUMAN 48 349 DBREF 6G78 B 48 349 UNP Q9UK32 KS6A6_HUMAN 48 349 SEQADV 6G78 GLY A 43 UNP Q9UK32 EXPRESSION TAG SEQADV 6G78 PRO A 44 UNP Q9UK32 EXPRESSION TAG SEQADV 6G78 LEU A 45 UNP Q9UK32 EXPRESSION TAG SEQADV 6G78 GLY A 46 UNP Q9UK32 EXPRESSION TAG SEQADV 6G78 SER A 47 UNP Q9UK32 EXPRESSION TAG SEQADV 6G78 GLU A 232 UNP Q9UK32 SER 232 ENGINEERED MUTATION SEQADV 6G78 GLY B 43 UNP Q9UK32 EXPRESSION TAG SEQADV 6G78 PRO B 44 UNP Q9UK32 EXPRESSION TAG SEQADV 6G78 LEU B 45 UNP Q9UK32 EXPRESSION TAG SEQADV 6G78 GLY B 46 UNP Q9UK32 EXPRESSION TAG SEQADV 6G78 SER B 47 UNP Q9UK32 EXPRESSION TAG SEQADV 6G78 GLU B 232 UNP Q9UK32 SER 232 ENGINEERED MUTATION SEQRES 1 A 307 GLY PRO LEU GLY SER ASP GLU GLY VAL VAL LYS GLU ILE SEQRES 2 A 307 PRO ILE THR HIS HIS VAL LYS GLU GLY TYR GLU LYS ALA SEQRES 3 A 307 ASP PRO ALA GLN PHE GLU LEU LEU LYS VAL LEU GLY GLN SEQRES 4 A 307 GLY SER PHE GLY LYS VAL PHE LEU VAL ARG LYS LYS THR SEQRES 5 A 307 GLY PRO ASP ALA GLY GLN LEU TYR ALA MET LYS VAL LEU SEQRES 6 A 307 LYS LYS ALA SER LEU LYS VAL ARG ASP ARG VAL ARG THR SEQRES 7 A 307 LYS MET GLU ARG ASP ILE LEU VAL GLU VAL ASN HIS PRO SEQRES 8 A 307 PHE ILE VAL LYS LEU HIS TYR ALA PHE GLN THR GLU GLY SEQRES 9 A 307 LYS LEU TYR LEU ILE LEU ASP PHE LEU ARG GLY GLY ASP SEQRES 10 A 307 VAL PHE THR ARG LEU SER LYS GLU VAL LEU PHE THR GLU SEQRES 11 A 307 GLU ASP VAL LYS PHE TYR LEU ALA GLU LEU ALA LEU ALA SEQRES 12 A 307 LEU ASP HIS LEU HIS GLN LEU GLY ILE VAL TYR ARG ASP SEQRES 13 A 307 LEU LYS PRO GLU ASN ILE LEU LEU ASP GLU ILE GLY HIS SEQRES 14 A 307 ILE LYS LEU THR ASP PHE GLY LEU SER LYS GLU SER VAL SEQRES 15 A 307 ASP GLN GLU LYS LYS ALA TYR GLU PHE CYS GLY THR VAL SEQRES 16 A 307 GLU TYR MET ALA PRO GLU VAL VAL ASN ARG ARG GLY HIS SEQRES 17 A 307 SER GLN SER ALA ASP TRP TRP SER TYR GLY VAL LEU MET SEQRES 18 A 307 PHE GLU MET LEU THR GLY THR LEU PRO PHE GLN GLY LYS SEQRES 19 A 307 ASP ARG ASN GLU THR MET ASN MET ILE LEU LYS ALA LYS SEQRES 20 A 307 LEU GLY MET PRO GLN PHE LEU SER ALA GLU ALA GLN SER SEQRES 21 A 307 LEU LEU ARG MET LEU PHE LYS ARG ASN PRO ALA ASN ARG SEQRES 22 A 307 LEU GLY SER GLU GLY VAL GLU GLU ILE LYS ARG HIS LEU SEQRES 23 A 307 PHE PHE ALA ASN ILE ASP TRP ASP LYS LEU TYR LYS ARG SEQRES 24 A 307 GLU VAL GLN PRO PRO PHE LYS PRO SEQRES 1 B 307 GLY PRO LEU GLY SER ASP GLU GLY VAL VAL LYS GLU ILE SEQRES 2 B 307 PRO ILE THR HIS HIS VAL LYS GLU GLY TYR GLU LYS ALA SEQRES 3 B 307 ASP PRO ALA GLN PHE GLU LEU LEU LYS VAL LEU GLY GLN SEQRES 4 B 307 GLY SER PHE GLY LYS VAL PHE LEU VAL ARG LYS LYS THR SEQRES 5 B 307 GLY PRO ASP ALA GLY GLN LEU TYR ALA MET LYS VAL LEU SEQRES 6 B 307 LYS LYS ALA SER LEU LYS VAL ARG ASP ARG VAL ARG THR SEQRES 7 B 307 LYS MET GLU ARG ASP ILE LEU VAL GLU VAL ASN HIS PRO SEQRES 8 B 307 PHE ILE VAL LYS LEU HIS TYR ALA PHE GLN THR GLU GLY SEQRES 9 B 307 LYS LEU TYR LEU ILE LEU ASP PHE LEU ARG GLY GLY ASP SEQRES 10 B 307 VAL PHE THR ARG LEU SER LYS GLU VAL LEU PHE THR GLU SEQRES 11 B 307 GLU ASP VAL LYS PHE TYR LEU ALA GLU LEU ALA LEU ALA SEQRES 12 B 307 LEU ASP HIS LEU HIS GLN LEU GLY ILE VAL TYR ARG ASP SEQRES 13 B 307 LEU LYS PRO GLU ASN ILE LEU LEU ASP GLU ILE GLY HIS SEQRES 14 B 307 ILE LYS LEU THR ASP PHE GLY LEU SER LYS GLU SER VAL SEQRES 15 B 307 ASP GLN GLU LYS LYS ALA TYR GLU PHE CYS GLY THR VAL SEQRES 16 B 307 GLU TYR MET ALA PRO GLU VAL VAL ASN ARG ARG GLY HIS SEQRES 17 B 307 SER GLN SER ALA ASP TRP TRP SER TYR GLY VAL LEU MET SEQRES 18 B 307 PHE GLU MET LEU THR GLY THR LEU PRO PHE GLN GLY LYS SEQRES 19 B 307 ASP ARG ASN GLU THR MET ASN MET ILE LEU LYS ALA LYS SEQRES 20 B 307 LEU GLY MET PRO GLN PHE LEU SER ALA GLU ALA GLN SER SEQRES 21 B 307 LEU LEU ARG MET LEU PHE LYS ARG ASN PRO ALA ASN ARG SEQRES 22 B 307 LEU GLY SER GLU GLY VAL GLU GLU ILE LYS ARG HIS LEU SEQRES 23 B 307 PHE PHE ALA ASN ILE ASP TRP ASP LYS LEU TYR LYS ARG SEQRES 24 B 307 GLU VAL GLN PRO PRO PHE LYS PRO HET ANP A 401 31 HET ANP B 401 31 HETNAM ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER FORMUL 3 ANP 2(C10 H17 N6 O12 P3) FORMUL 5 HOH *85(H2 O) HELIX 1 AA1 ASP A 69 ALA A 71 5 3 HELIX 2 AA2 ILE A 126 VAL A 130 1 5 HELIX 3 AA3 VAL A 160 LYS A 166 1 7 HELIX 4 AA4 THR A 171 GLN A 191 1 21 HELIX 5 AA5 LYS A 200 GLU A 202 5 3 HELIX 6 AA6 THR A 236 MET A 240 5 5 HELIX 7 AA7 ALA A 241 ASN A 246 1 6 HELIX 8 AA8 SER A 251 GLY A 269 1 19 HELIX 9 AA9 ASP A 277 ALA A 288 1 12 HELIX 10 AB1 SER A 297 PHE A 308 1 12 HELIX 11 AB2 VAL A 321 ARG A 326 1 6 HELIX 12 AB3 HIS A 327 ALA A 331 5 5 HELIX 13 AB4 ASP A 334 LYS A 340 1 7 HELIX 14 AB5 ASP B 69 ALA B 71 5 3 HELIX 15 AB6 ILE B 126 VAL B 130 1 5 HELIX 16 AB7 VAL B 160 LYS B 166 1 7 HELIX 17 AB8 THR B 171 LEU B 192 1 22 HELIX 18 AB9 LYS B 200 GLU B 202 5 3 HELIX 19 AC1 THR B 236 MET B 240 5 5 HELIX 20 AC2 ALA B 241 ASN B 246 1 6 HELIX 21 AC3 SER B 251 GLY B 269 1 19 HELIX 22 AC4 ASP B 277 ALA B 288 1 12 HELIX 23 AC5 SER B 297 PHE B 308 1 12 HELIX 24 AC6 GLY B 320 ARG B 326 1 7 HELIX 25 AC7 HIS B 327 ALA B 331 5 5 HELIX 26 AC8 ASP B 334 LYS B 340 1 7 SHEET 1 AA1 4 VAL A 52 PRO A 56 0 SHEET 2 AA1 4 LEU A 101 ARG A 115 -1 O VAL A 114 N LYS A 53 SHEET 3 AA1 4 GLY A 85 LYS A 92 -1 N VAL A 90 O TYR A 102 SHEET 4 AA1 4 PHE A 73 GLY A 82 -1 N LYS A 77 O LEU A 89 SHEET 1 AA2 5 HIS A 60 VAL A 61 0 SHEET 2 AA2 5 LEU A 138 THR A 144 -1 O ALA A 141 N HIS A 60 SHEET 3 AA2 5 LYS A 147 ASP A 153 -1 O ILE A 151 N TYR A 140 SHEET 4 AA2 5 LEU A 101 ARG A 115 -1 N ALA A 103 O LEU A 152 SHEET 5 AA2 5 LEU A 219 SER A 223 -1 O SER A 220 N SER A 111 SHEET 1 AA3 3 GLY A 158 ASP A 159 0 SHEET 2 AA3 3 ILE A 204 LEU A 206 -1 O LEU A 206 N GLY A 158 SHEET 3 AA3 3 ILE A 212 LEU A 214 -1 O LYS A 213 N LEU A 205 SHEET 1 AA4 3 VAL B 52 ILE B 57 0 SHEET 2 AA4 3 LYS B 109 ARG B 115 -1 O ALA B 110 N ILE B 57 SHEET 3 AA4 3 LEU B 219 GLU B 222 -1 O SER B 220 N SER B 111 SHEET 1 AA5 6 HIS B 60 VAL B 61 0 SHEET 2 AA5 6 LEU B 138 GLN B 143 -1 O ALA B 141 N HIS B 60 SHEET 3 AA5 6 LEU B 148 LEU B 152 -1 O ILE B 151 N HIS B 139 SHEET 4 AA5 6 LEU B 101 LEU B 107 -1 N LEU B 107 O LEU B 148 SHEET 5 AA5 6 GLY B 85 LYS B 92 -1 N VAL B 90 O TYR B 102 SHEET 6 AA5 6 PHE B 73 GLY B 82 -1 N LEU B 76 O LEU B 89 SHEET 1 AA6 3 GLY B 158 ASP B 159 0 SHEET 2 AA6 3 ILE B 204 LEU B 206 -1 O LEU B 206 N GLY B 158 SHEET 3 AA6 3 ILE B 212 LEU B 214 -1 O LYS B 213 N LEU B 205 SITE 1 AC1 17 LEU A 79 GLY A 80 GLY A 82 SER A 83 SITE 2 AC1 17 PHE A 84 VAL A 87 ALA A 103 LYS A 105 SITE 3 AC1 17 ASP A 153 LEU A 155 LYS A 200 GLU A 202 SITE 4 AC1 17 ASN A 203 LEU A 205 THR A 215 LYS A 221 SITE 5 AC1 17 HOH A 514 SITE 1 AC2 19 LEU B 79 GLY B 80 GLY B 82 SER B 83 SITE 2 AC2 19 PHE B 84 GLY B 85 VAL B 87 ALA B 103 SITE 3 AC2 19 LYS B 105 ASP B 153 LEU B 155 ASP B 198 SITE 4 AC2 19 LYS B 200 GLU B 202 ASN B 203 LEU B 205 SITE 5 AC2 19 THR B 215 LYS B 221 HOH B 505 CRYST1 52.015 110.614 66.559 90.00 90.22 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019225 0.000000 0.000074 0.00000 SCALE2 0.000000 0.009040 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015024 0.00000